Drug Trial Radar · NCT01873547
Different Efficacy Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With SCI in China
Last checked: Nov 20, 2026Latest source record: May 25, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Jun 2012
Primary completion
Oct 2014
Study completion Dec 2015
Sponsor
- Lead sponsor
- General Hospital of Chinese Armed Police ForcesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 10, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The morbidity of spinal cord injury (SCI) is increasing year by year significantly in China. The methods to treat SCI patients in sequela stage update are poor. Though traditional rehabilitation therapy is the routine method to treat SCI in sequela stage, aiming to improve the neurological disorders of these patients, such as sensory disturbance, dyskinesia, autologous adjustment of blood pressure, dysfunction of urination, defecation and perspiration , etc. What's a pity, the efficacy of the rehabilitation therapy is unsatisfactory. Rehabilitation Therapy can prevent the process of muscle atrophy and joint stiffness. However, it can not repair the damaged nerve function. Studies show that mesenchymal stem cell transplantation can remarkably improve the neurological function of SCI in animals without any severe side effect. In this study, 300 patients will be divided into three groups and the investigators will use mesenchymal stem cells derived from umbilical cord to treat 100 SCI patients. They will also follow up 100 patients who only receive rehabilitation and another 100 patients who accept neither stem cell therapy nor rehabilitation. On this basis, the investigators can compare the efficacy of these two treatments.
Conditions
- Spinal Cord Injury
Interventions
cell therapyBiological
Mesenchymal stem cells derived from umbilical cord are transplanted directly into subarachnoid by Lumbar puncture.
rehabilitationOther
Patients only receive rehabilitation of limb function.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of changes in International Standards for Neurological Classification of Spinal Cord Injury according to American Spine Injury AssociationTime frame: Baseline, 6 and 12 months after recruitment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
General Hospital of Chinese People's Armed Police Forces
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.